The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic tension-type headache, chronic cluster headache, hemicrania continua) is challenging as serious side effects frequently complicate the course of medical treatment and some patients may be even medically intractable. When a definitive lack of responsiveness to conservative treatments is ascertained and medication overuse headache is excluded, neuromodulation options can be considered in selected cases
Abstract Chronic migraine (CM) is a disabling neuro-logical condition affecting 0.5–2 % of the popul...
Chronic migraine afflicts 1-5 % of the global population and poses a substantial burden on subjects ...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5–2 % of the population. In ...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
Primary headache disorders are among the most common and disabling globally. Pharmacological treatme...
Chronic migraine afflicts 1-5% of the global population and poses a substantial burden on subjects’ ...
Headache is the commonest symptom seen in both primary and secondary care. Vast majority are primary...
Background Headache remains the most common cause of neurological consultation in clinical practice ...
Chronic daily headache is a major worldwide health problem that affects 3–5% of the population and r...
Neuromodulation is a new promising treatment for headache disorders. It consists of peripheral nerve...
Introduction: Headache, a devastating painful symptom is one of the most common complaint in the wor...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Abstract Chronic migraine (CM) is a disabling neuro-logical condition affecting 0.5–2 % of the popul...
Chronic migraine afflicts 1-5 % of the global population and poses a substantial burden on subjects ...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5–2 % of the population. In ...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
The medical treatment of patients with chronic primary headache syndromes (chronic migraine, chronic...
Primary headache disorders are among the most common and disabling globally. Pharmacological treatme...
Chronic migraine afflicts 1-5% of the global population and poses a substantial burden on subjects’ ...
Headache is the commonest symptom seen in both primary and secondary care. Vast majority are primary...
Background Headache remains the most common cause of neurological consultation in clinical practice ...
Chronic daily headache is a major worldwide health problem that affects 3–5% of the population and r...
Neuromodulation is a new promising treatment for headache disorders. It consists of peripheral nerve...
Introduction: Headache, a devastating painful symptom is one of the most common complaint in the wor...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In ...
Abstract Chronic migraine (CM) is a disabling neuro-logical condition affecting 0.5–2 % of the popul...
Chronic migraine afflicts 1-5 % of the global population and poses a substantial burden on subjects ...
Chronic migraine (CM) is a disabling neurological condition affecting 0.5–2 % of the population. In ...